CSIMarket
 
Aerie Pharmaceuticals Inc   (AERI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $17.4500 $0.06 0.345%
Day's High: $17.72 Week Perf: -4.85 %
Day's Low: $ 17.07 30 Day Perf: -11.38 %
Volume (M): 390 52 Wk High: $ 21.30
Volume (M$): $ 6,797 52 Wk Avg: $14.25
Open: $17.41 52 Wk Low: $9.01



 Market Capitalization (Millions $) 802
 Shares Outstanding (Millions) 46
 Employees -
 Revenues (TTM) (Millions $) 83
 Net Income (TTM) (Millions $) -183
 Cash Flow (TTM) (Millions $) 8
 Capital Exp. (TTM) (Millions $) 3

Aerie Pharmaceuticals Inc


   Company Address: 4301 Emperor Boulevard, Durham, 27703 NC
   Company Phone Number: 237-5300   Stock Exchange / Ticker: NASDAQ AERI
   AERI is expected to report next financial results on February 24, 2022.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Cannabis Sativa Inc

Logged a Loss, Sales Faded

Declining demand caused increase in loss for the financial time frame ending Dec 31 2020, company's loss per share grew to $-0.02 from $-0.10 where Sales fell by -20.56% to $0.36 millions from $0.45 millions a year ago.

In contrast to the third quarter Sales fell by -21.43% from $0.46 millions and from $-0.02 per share.
Cannabis Sativa Inc reported net loss of $-2.46 millions and Sales of $2.04 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.09 from $-0.18 in the previous fiscal year, while Sales surged by 75.5 % from $1.16 millions a year ago.

Ameramex International Inc

Break-even, Sales Faded

For the fourth quarter of 2020 Ameramex International Inc reached break-even at $-0.00 per share, compared to results of $-0.00 per share a year ago quarter, In the previous quarter company realized $0.00 per share.

Sales Tumbled by -45.96% from $5.88 millions in preceding quarter, from $0.00 per share.
Cannabis Sativa Inc reported net loss of $-2.46 millions and Sales of $2.04 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.09 from $-0.18 in the previous fiscal year, while Sales surged by 75.5 % from $1.16 millions a year ago.

Trebia Acquisition Corp

Income Tumbles , Sales Faded

For the fourth quarter of 2020 Trebia Acquisition Corp income fell sharply at $0.01 per share, compared to results of $-0.00 per share a year ago quarter, In the previous quarter company realized $-0.01 per share.

from $0.00 millions in preceding quarter, EPS turn positive from $-0.01 per share.
Cannabis Sativa Inc reported net loss of $-2.46 millions and Sales of $2.04 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.09 from $-0.18 in the previous fiscal year, while Sales surged by 75.5 % from $1.16 millions a year ago.

Mudrick Capital Acquisition Corp Ii

Mudrick Capital Acquisition Corp Ii announced financial fourth quarter of 2020 operating loss of $0 millions

For the financial fourth quarter of 2020 Mudrick Capital Acquisition Corp Ii reached break-even at $0.00 per share, compared to results of $-0.00 per share a year ago quarter, In the previous quarter company realized $0.00 per share.

from $0.00 millions in preceding quarter, from $0.00 per share.
Mudrick Capital Acquisition Corp Ii reported net loss of $-0.10 millions and Sales of $0.00 millions for the fiscal year 2020.

Company reported break-even compared to $0.00 in the previous fiscal year, while by 0 % from $12.66 millions a year ago.

Social Capital Hedosophia Holdings Corp Iv

Break-even, Sales Faded

For the most recent fiscal period Social Capital Hedosophia Holdings Corp Iv reached break-even at $0.00 per share, compared to results of $-0.00 per share a year ago quarter, In the previous quarter company realized $0.00 per share.

from $0.00 millions in preceding quarter, from $0.00 per share.
Social Capital Hedosophia Holdings Corp Iv reported net loss of $-0.26 millions and Sales of $0.00 millions for the fiscal year 2020.

Company reported break-even compared to $0.00 in the previous fiscal year, while by 0 % from $12.66 millions a year ago.






 

Aerie Pharmaceuticals Inc 's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DCTH's Profile

Stock Price

DCTH's Financials

Business Description

Fundamentals

Charts & Quotes

DCTH's News

Suppliers

DCTH's Competitors

Customers & Markets

Economic Indicators

DCTH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071